Boiling and ready to burst as Syndax Pharmaceuticals Inc. (SNDX) last month performance was 17.98%

At the end of the latest market close, Syndax Pharmaceuticals Inc. (SNDX) was valued at $18.95. In that particular session, Stock kicked-off at the price of $20.50 while reaching the peak value of $21.25 and lowest value recorded on the day was $19.33. The stock current value is $19.75.

Recently in News on November 4, 2020, Syndax Pharmaceuticals to Present Updated Data from Phase 1 Trial of Axatilimab in cGVHD During Oral Session at the 62nd ASH Annual Meeting. – Response rate of ~60% observed in patients following a median of five prior lines of treatment -. You can read further details here

My Next COVID-19 Stock Alert Poised For Triple Digit Moves

Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.    

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<


Syndax Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $21.97 on 05/19/20, with the lowest value was $6.32 for the same time period, recorded on 01/30/20.

Syndax Pharmaceuticals Inc. (SNDX) full year performance was 175.45%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Syndax Pharmaceuticals Inc. shares are logging -10.10% during the 52-week period from high price, and 269.16% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $5.35 and $21.97.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1959850 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Syndax Pharmaceuticals Inc. (SNDX) recorded performance in the market was 124.94%, having the revenues showcasing 31.67% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 788.82M, as it employees total of 35 workers.

Specialists analysis on Syndax Pharmaceuticals Inc. (SNDX)

During the last month, 0 analysts gave the Syndax Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 15.64, with a change in the price was noted +3.49. In a similar fashion, Syndax Pharmaceuticals Inc. posted a movement of +21.46% for the period of last 100 days, recording 415,782 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for SNDX is recording 0.13 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.13.

Trends and Technical analysis: Syndax Pharmaceuticals Inc. (SNDX)

Raw Stochastic average of Syndax Pharmaceuticals Inc. in the period of last 50 days is set at 81.34%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 77.17%. In the last 20 days, the company’s Stochastic %K was 72.30% and its Stochastic %D was recorded 68.50%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 124.94%. Additionally, trading for the stock in the period of the last six months notably improved by 9.66%, alongside a boost of 175.45% for the period of the last 12 months. The shares increased approximately by 11.27% in the 7-day charts and went down by 17.98% in the period of the last 30 days. Common stock shares were driven by 31.67% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free